PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China.\', \'The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese Ministry of Health and Chinese Academy of Medical Sciences, Department of Cardiology, Qilu Hospital of Shandong University, Jinan 250012, China.\', \'Department of Cardiology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3760/cma.j.issn.1001-0939.2020.03.016
?:hasPublicationType
?:journal
  • Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
is ?:pmid of
?:pmid
?:pmid
  • 32164092
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.142
?:rankingScore_hIndex
  • 15
is ?:relation_isRelatedTo_publication of
?:title
  • [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all